General MedicationsORALStandard
LODOSYN
CARBIDOPA
Standard Dose
25MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview LODOSYN is listed in Drugs@FDA under application 017830 (NDA).
Marketing status: Prescription Active ingredient CARBIDOPA Form and strength TABLET;ORAL - 25MG Sponsor ATON Submission history Latest submission status date: 2014-02-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview LODOSYN is listed in Drugs@FDA under application 017830 (NDA). Marketing status: Prescription Active ingredient CARBIDOPA Form and strength TABLET;ORAL - 25MG Sponsor ATON Submission history Latest submission status date: 2014-02-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.